Oncolytics Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.About ONCY
Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
CEOWayne F. Pisano
CEOWayne F. Pisano
Employees28
Employees28
HeadquartersCalgary, Alberta
HeadquartersCalgary, Alberta
Founded1998
Founded1998
Employees28
Employees28
ONCY Key Statistics
Market cap39.99M
Market cap39.99M
Price-Earnings ratio-1.62
Price-Earnings ratio-1.62
Dividend yield—
Dividend yield—
Average volume284.62K
Average volume284.62K
High today$0.53
High today$0.53
Low today$0.4506
Low today$0.4506
Open price$0.491
Open price$0.491
Volume928.69K
Volume928.69K
52 Week high$1.53
52 Week high$1.53
52 Week low$0.45
52 Week low$0.45
ONCY News
TipRanks 3d
Oncolytics Biotech Reports Q1 2025 Financial ResultsConfident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive underval...
People also own
Based on the portfolios of people who own ONCY. This list is generated using Robinhood data, and it’s not a recommendation.